Skip to content

Effect of fenugreek seed extract on oxidative stress in type 2 diabetic patients

The Effect of Fenugreek Seed Extract Supplementation on Blood glucose,Lipid profile, Appetite, Energy Intake and Macronutrient, Oxidative stress in Patients with Type 2 Diabetes:Randomized Double-blind Controlled clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210407050881N1
Enrollment
46
Registered
2022-01-04
Start date
2021-08-06
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Dry extract of fenugreek seeds of Barij Essential Oil Company called "Glucorx B" (containing 46.4 micrograms of luteolin per tablet) will be consumed in the form of
Therefore, the amount of reduction in calories per person will not be a fixed amount. To calculate calories, BMR (using the Myfeline formula) will be multiplied by physical activity and TEF. People in

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients in the age range of 30-65 years Having at least 6 months of diabetes history (according to criteria of American Diabetes Association) BMI between 25 and 35 Taking blood sugar lowering drugs No herbs at least 3 months before the study to be used routinely Willingness to participate in the project

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding or its intention Kidney, liver, gastrointestinal, thyroid, and rheumatic diseases Allergy to plants of the Fabaceae family

Design outcomes

Primary

MeasureTime frame
Fasting blood suger. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Measurement of blood levels using electrochemical methods.;Serum insulin. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Measurement of serum level by ELISA kit.;Insulin resistance. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Formula calculation.;Triglyceride. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Measurement of serum level using spectrophotometric method.;LDL. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Friedwald Computational Method.;HDL. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Measurement of serum level using spectrophotometric method.;Total cholestrol. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Measurement of serum level using spectrophotometric method.;PAB. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Measurement of serum level by ELISA kit.;Appetite. Timepoint: Before intervention and 2 months after intervention. Method of measurement: questionnaire.;Calorie intake. Timepoint: Before intervention and 2 months after intervention. Method of measurement: questionnaire(Finally, energy calculation using n4 software).;Macronutrients intake. Timepoint: Before intervention and 2 months after intervention. Method of measurement: n4 software.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Chehregosha

Tabriz University of Medical Sciences

fatemehchehregosha4@gmail.com+98 41 3335 5921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026